Old Web
English
Sign In
Acemap
>
authorDetail
>
Paula Persson
Paula Persson
Novo Nordisk
Medicine
Pharmacokinetics
Dosing
Body mass index
Octapharma
4
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Favorable pharmacokinetics in hemophilia B for nonacog beta pegol versus recombinant factor IX‐Fc fusion protein: A randomized trial
2019
Carmen Escuriola Ettingshausen
Inga Hegemann
Mindy L. Simpson
Adam Cuker
Roshni Kulkarni
Rajiv K. Pruthi
May-Lill Garly
Rikke M. Meldgaard
Paula Persson
R. Klamroth
Show All
Source
Cite
Save
Citations (7)
Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A.
2019
Thrombosis and Haemostasis
Andreas Tiede
Ana Rosa Cid
Georg Goldmann
Victor Jiménez Yuste
Michael Pluta
Toshko Lissitchkov
Marcus May
Irina Matytsina
Predrag Miljic
Ingrid Pabinger
Paula Persson
Show All
Source
Cite
Save
Citations (3)
A New Dosing Model Based on Body Mass Index to Guide Factor VIII Dosing in Patients with Hemophilia A
2018
Blood
Andreas Tiede
Georg Goldmann
Predrag Miljić
Lars Korsholm
Irina Matytsina
Paula Persson
Toshko Lissitchkov
Show All
Source
Cite
Save
Citations (0)
Safety, Efficacy and Pharmacokinetics of Nonacog Beta Pegol (N9-GP) in Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Pediatric Hemophilia B Patients
2014
Blood
Manuel Carcao
Marek Zak
Fara Abdul Karim
Hideji Hanabusa
Susan Kearney
Meng-Yao Lu
Paula Persson
Savita Rangarajan
Elena Santagostino
Show All
Source
Cite
Save
Citations (2)
1